Posted Feb. 21, 2012 at 1:46 p.m.

Premium Lock Charlotte firm's Parkinson drug candidate is in trouble

Published: 2012-02-21 13:46:06
Updated: 2012-02-21 13:46:06

Chelsea Chelsea

The U.S. Food and Drug Administration reviewer for Northera has recommended the agency not approve the drug being developed by Chelsea Therapeutics....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders